Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Gregory A. Abel, M.D.

Title
Institution
Department
Address
Phone
Fax

Mentoring
Quality of End-of-Life Care for the Myelodysplastic Syndromes: Findings from a Large National Database
Summer, 06/01/15 - 08/27/15

Research
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. U54CA156732 (VISWANATH, KASISOMAYAJULA) Sep 27, 2010 - Aug 31, 2021
    NIH/NCI
    2/2 The University of Massachusetts, Boston - Dana-Farber/Harvard Cancer Center U54 Comprehensive Partnership for Cancer Disparities Research
    Role: Co-Principal Investigator

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Hantel A, Abel GA. An Action Plan for Environmentally Sustainable Cancer Care. JAMA Oncol. 2020 Feb 06. PMID: 32027350.
    Citations:    
  2. Henckel C, Revette A, Huntington SF, Tulsky JA, Abel GA, Odejide OO. Perspectives Regarding Hospice Services and Transfusion Access: Focus Groups With Blood Cancer Patients and Bereaved Caregivers. J Pain Symptom Manage. 2020 Jan 09. PMID: 31926969.
    Citations:    
  3. Loh KP, Xu H, Back A, Duberstein PR, Gupta Mohile S, Epstein R, McHugh C, Klepin HD, Abel G, Lee SJ, El-Jawahri A, LeBlanc TW. Patient-hematologist discordance in perceived chance of cure in hematologic malignancies: A multicenter study. Cancer. 2020 Mar 15; 126(6):1306-1314. PMID: 31809566.
    Citations:    
  4. Odejide OO, Uno H, Murillo A, Tulsky JA, Abel GA. Goals of care discussions for patients with blood cancers: Association of person, place, and time with end-of-life care utilization. Cancer. 2020 Feb 01; 126(3):515-522. PMID: 31593321.
    Citations:    
  5. Punglia RS, Ortiz Pimentel S, Cronin AM, Frank ES, Bellon JR, Abel GA, Uno H, Wong JS. Patient-preferred outcomes measurement after post-mastectomy radiation therapy and immediate reconstruction. Breast J. 2020 02; 26(2):319-321. PMID: 31495035.
    Citations:    
  6. Slavin SD, Fenech A, Jankowski AL, Abel GA, Brunner AM, Steensma DP, Fathi AT, DeAngelo DJ, Wadleigh M, Hobbs GS, Amrein PC, Stone RM, Temel JS, El-Jawahri A. Outcomes for older adults with acute myeloid leukemia after an intensive care unit admission. Cancer. 2019 Nov 01; 125(21):3845-3852. PMID: 31299106.
    Citations:    
  7. Hantel A, Abel GA, Siegler M. Practical allocation system for the distribution of specialised care during cellular therapy access scarcity. J Med Ethics. 2019 Aug; 45(8):532-537. PMID: 31217227.
    Citations:    
  8. Liu MA, DuMontier C, Murillo A, Hshieh TT, Bean JF, Soiffer RJ, Stone RM, Abel GA, Driver JA. Gait speed, grip strength, and clinical outcomes in older patients with hematologic malignancies. Blood. 2019 07 25; 134(4):374-382. PMID: 31167800.
    Citations:    
  9. Sekeres MA, Gore SD, Stablein DM, DiFronzo N, Abel GA, DeZern AE, Troy JD, Rollison DE, Thomas JW, Waclawiw MA, Liu JJ, Al Baghdadi T, Walter MJ, Bejar R, Gorak EJ, Starczynowski DT, Foran JM, Cerhan JR, Moscinski LC, Komrokji RS, Deeg HJ, Epling-Burnette PK. The National MDS Natural History Study: design of an integrated data and sample biorepository to promote research studies in myelodysplastic syndromes. Leuk Lymphoma. 2019 Dec; 60(13):3161-3171. PMID: 31111762.
    Citations:    
  10. Albelda R, Wiemers E, Hahn T, Khera N, Salas Coronado DY, Abel GA. Relationship between paid leave, financial burden, and patient-reported outcomes among employed patients who have undergone bone marrow transplantation. Qual Life Res. 2019 Jul; 28(7):1835-1847. PMID: 31030364.
    Citations:    
  11. DuMontier C, Liu MA, Murillo A, Hshieh T, Javedan H, Soiffer R, Stone RM, Driver JA, Abel GA. Function, Survival, and Care Utilization Among Older Adults With Hematologic Malignancies. J Am Geriatr Soc. 2019 May; 67(5):889-897. PMID: 30945759.
    Citations:    
  12. Abel GA. Pentito. JAMA Oncol. 2019 04 01; 5(4):580. PMID: 30763415.
    Citations:    
  13. El-Jawahri A, Abel GA, Traeger L, Waldman L, Markovitz N, VanDusen H, Fathi A, Steensma DP, LeBlanc TW, Horick NK, DeAngelo DJ, Wadleigh M, Hobbs G, Foster J, Brunner AM, Amrein P, Stone RM, Temel JS, Greer JA. Quality of life and mood of older patients with acute myeloid leukemia (AML) receiving intensive and non-intensive chemotherapy. Leukemia. 2019 10; 33(10):2393-2402. PMID: 30923318.
    Citations:    
  14. Solle JC, Steinberg A, Marathe P, Gray TF, Emmert A, Abel GA. Patients as experts: characterizing the most relevant patient-reported outcomes after hematopoietic cell transplantation. Bone Marrow Transplant. 2020 Jan; 55(1):242-244. PMID: 30918338.
    Citations:    
  15. Habib AR, Cronin AM, Earle CC, Tulsky JA, Mack JW, Abel GA, Odejide OO. How Do Blood Cancer Doctors Discuss Prognosis? Findings from a National Survey of Hematologic Oncologists. J Palliat Med. 2019 06; 22(6):677-684. PMID: 30907686.
    Citations:    
  16. Abel GA. The Best Medicine. JAMA Oncol. 2019 03 01; 5(3):350. PMID: 30703207.
    Citations:    Fields:    
  17. Pories SE, Piawah S, Abel GA, Mullangi S, Doyle J, Katz JT. What is the Role of the Arts in Medical Education and Patient Care? A Survey-based Qualitative Study. J Med Humanit. 2018 Dec; 39(4):431-445. PMID: 30076508.
    Citations:    Fields:    
  18. Hshieh TT, Driver JA, Abel GA. Cognitive Impairment Among Older Patients With Hematologic Cancers-Reply. JAMA Oncol. 2018 12 01; 4(12):1784. PMID: 30286229.
    Citations:    
  19. Murillo A, Cronin AM, Laubach JP, Hshieh TT, Tanasijevic AM, Richardson PG, Driver JA, Abel GA. Performance of the International Myeloma Working Group myeloma frailty score among patients 75 and older. J Geriatr Oncol. 2019 05; 10(3):486-489. PMID: 30472368.
    Citations:    Fields:    
  20. Khera N, Hamilton BK, Pidala JA, Wood WA, Wu V, Voutsinas J, Onstad L, Alousi AM, Broady R, Chen GL, Arora M, Cutler C, Flowers ME, Ganetsky A, Jagasia M, McCarthy PL, Sarantopoulos S, Abel GA, Majhail NS, Lee SJ. Employment, Insurance, and Financial Experiences of Patients with Chronic Graft-versus-Host Disease in North America. Biol Blood Marrow Transplant. 2019 03; 25(3):599-605. PMID: 30296479.
    Citations:    Fields:    
  21. McCleary NJ, Healey MJ, Weng S, Song AB, Lederman RI, Ramelson HZ, Wagner AJ, Abel GA. Perceptions of Oncologists About Sharing Clinic Notes with Patients. Oncologist. 2019 01; 24(1):e46-e48. PMID: 30254186.
    Citations:    Fields:    
  22. Brunner AM, Weng S, Cronin A, Fathi AT, Habib AR, Stone R, Graubert T, Steensma DP, Abel GA. Impact of lenalidomide use among non-transfusion dependent patients with myelodysplastic syndromes. Am J Hematol. 2018 09; 93(9):1119-1126. PMID: 30033577.
    Citations:    Fields:    
  23. El-Jawahri A, Nelson-Lowe M, VanDusen H, Traeger L, Abel GA, Greer JA, Fathi A, Steensma DP, LeBlanc TW, Li Z, DeAngelo D, Wadleigh M, Hobbs G, Foster J, Brunner A, Amrein P, Stone RM, Temel JS. Patient-Clinician Discordance in Perceptions of Treatment Risks and Benefits in Older Patients with Acute Myeloid Leukemia. Oncologist. 2019 02; 24(2):247-254. PMID: 30139841.
    Citations:    Fields:    
  24. Odejide OO, Li L, Cronin AM, Murillo A, Richardson PG, Anderson KC, Abel GA. Meaningful changes in end-of-life care among patients with myeloma. Haematologica. 2018 08; 103(8):1380-1389. PMID: 29748440.
    Citations:    Fields:    
  25. Hshieh TT, Jung WF, Grande LJ, Chen J, Stone RM, Soiffer RJ, Driver JA, Abel GA. Prevalence of Cognitive Impairment and Association With Survival Among Older Patients With Hematologic Cancers. JAMA Oncol. 2018 05 01; 4(5):686-693. PMID: 29494732.
    Citations: 1     Fields:    
  26. Frosch ZAK, Cronin AM, Gagne JJ, Teschke MP, Gray SW, Abel GA. Cancer drug shortages: Awareness and perspectives from a representative sample of the US population. Cancer. 2018 05 15; 124(10):2205-2211. PMID: 29635808.
    Citations:    Fields:    
  27. Khera N, Albelda R, Hahn T, Coronado DS, Odejide OO, Soiffer RJ, Abel GA. Financial Hardship after Hematopoietic Cell Transplantation: Lack of Impact on Survival. Cancer Epidemiol Biomarkers Prev. 2018 03; 27(3):345-347. PMID: 29440120.
    Citations:    Fields:    
  28. Frosch ZAK, Gagne JJ, Gray SW, Abel GA. What Does a Cancer Diagnosis Mean? Public Expectations in a Shifting Therapeutic Environment. J Oncol Pract. 2018 03; 14(3):139-140. PMID: 29381410.
    Citations:    Fields:    
  29. Luskin MR, Abel GA. Management of older adults with myelodysplastic syndromes (MDS). J Geriatr Oncol. 2018 07; 9(4):302-307. PMID: 29290596.
    Citations:    Fields:    
  30. Efficace F, Cottone F, Abel G, Niscola P, Gaidano G, Bonnetain F, Anota A, Caocci G, Cronin A, Fianchi L, Breccia M, Stauder R, Platzbecker U, Palumbo GA, Luppi M, Invernizzi R, Bergamaschi M, Borin L, Di Tucci AA, Zhang H, Sprangers M, Vignetti M, Mandelli F. Patient-reported outcomes enhance the survival prediction of traditional disease risk classifications: An international study in patients with myelodysplastic syndromes. Cancer. 2018 03 15; 124(6):1251-1259. PMID: 29231969.
    Citations: 3     Fields:    
  31. Abel GA, Klepin HD. Frailty and the management of hematologic malignancies. Blood. 2018 02 01; 131(5):515-524. PMID: 29141942.
    Citations: 2     Fields:    Translation:Humans
  32. Brunner AM, Blonquist TM, Hobbs GS, Amrein PC, Neuberg DS, Steensma DP, Abel GA, Fathi AT. Risk and timing of cardiovascular death among patients with myelodysplastic syndromes. Blood Adv. 2017 Oct 24; 1(23):2032-2040. PMID: 29296849.
    Citations: 1     
  33. Zeidan AM, Long JB, Wang R, Hu X, Yu JB, Huntington SF, Abel GA, Mougalian SS, Podoltsev NA, Gore SD, Gross CP, Ma X, Davidoff AJ. Risk of myeloid neoplasms after radiotherapy among older women with localized breast cancer: A population-based study. PLoS One. 2017; 12(9):e0184747. PMID: 28902882.
    Citations: 1     Fields:    Translation:HumansPHPublic Health
  34. Abel GA. Aptitude; Mother's Day; Winter Beach. J Clin Oncol. 2017 Aug 20; 35(24):2848. PMID: 28537811.
    Citations:    Fields:    
  35. Odejide OO, Cronin AM, Earle CC, Tulsky JA, Abel GA. Why are patients with blood cancers more likely to die without hospice? Cancer. 2017 Sep 01; 123(17):3377-3384. PMID: 28542833.
    Citations: 4     Fields:    Translation:Humans
  36. Luskin MR, Cronin AM, Owens RL, DeAngelo DJ, Stone RM, Wadleigh M, Steensma DP, Abel GA. Self-reported sleep disturbance and survival in myelodysplastic syndromes. Br J Haematol. 2017 05; 177(4):562-566. PMID: 28272741.
    Citations:    Fields:    Translation:Humans
  37. Connell NT, Abel GA, Connors JM. Low-molecular weight heparin versus vitamin K antagonists for the treatment of cancer-associated thrombosis: A cost-effectiveness analysis. Thromb Res. 2017 Feb; 150:53-58. PMID: 28039844.
    Citations:    Fields:    Translation:Humans
  38. Frosch ZA, Abel GA. Assessing Quality of Care for the Myelodysplastic Syndromes. Curr Hematol Malig Rep. 2016 12; 11(6):402-407. PMID: 27562670.
    Citations: 1     Fields:    Translation:Humans
  39. Schnipper LE, Abel GA. Direct-to-Consumer Drug Advertising in Oncology Is Not Beneficial to Patients or Public Health. JAMA Oncol. 2016 Nov 01; 2(11):1397-1398. PMID: 27532895.
    Citations: 1     Fields:    Translation:Humans
  40. Nipp RD, Abel GA. Small Step for Geriatric Oncology That Could Have Been a Giant Leap. J Clin Oncol. 2016 11 20; 34(33):4048-4049. PMID: 27551124.
    Citations:    Fields:    
  41. Zhou Z, Rademaker AW, Gordon LI, LaCasce AS, Crosby-Thompson A, Vanderplas A, Abel GA, Rodriguez MA, Nademanee A, Kaminski MS, Czuczman MS, Millenson MM, Zelenetz AD, Niland J, Friedberg JW, Winter JN. High Body Mass Index in Elderly Patients With DLBCL Treated With Rituximab-Containing Therapy Compensates for Negative Impact of Male Sex. J Natl Compr Canc Netw. 2016 10; 14(10):1274-1281. PMID: 27697981.
    Citations:    Fields:    Translation:Humans
  42. Zeidan AM, Davidoff AJ, Long JB, Hu X, Wang R, Ma X, Gross CP, Abel GA, Huntington SF, Podoltsev NA, Hajime U, Prebet T, Gore SD. Comparative clinical effectiveness of azacitidine versus decitabine in older patients with myelodysplastic syndromes. Br J Haematol. 2016 Dec; 175(5):829-840. PMID: 27650975.
    Citations: 6     Fields:    Translation:Humans
  43. Zeidan AM, Wang R, Gross CP, Gore SD, Huntington SF, Prebet T, Abel GA, Davidoff AJ, Ma X. Modest improvement in survival of patients with refractory anemia with excess blasts in the hypomethylating agents era in the United States. Leuk Lymphoma. 2017 04; 58(4):982-985. PMID: 27558206.
    Citations: 3     Fields:    Translation:HumansCells
  44. Liu MA, Hshieh T, Condron N, Wadleigh M, Abel GA, Driver JA. Relationship between physician and patient assessment of performance status and survival in a large cohort of patients with haematologic malignancies. Br J Cancer. 2016 09 27; 115(7):858-61. PMID: 27552440.
    Citations: 1     Fields:    Translation:Humans
  45. Odejide OO, Cronin AM, Condron NB, Fletcher SA, Earle CC, Tulsky JA, Abel GA. Barriers to Quality End-of-Life Care for Patients With Blood Cancers. J Clin Oncol. 2016 09 10; 34(26):3126-32. PMID: 27400944.
    Citations: 10     Fields:    Translation:Humans
  46. El-Jawahri A, Keenan T, Abel GA, Steensma DP, LeBlanc TW, Chen YB, Hobbs G, Traeger L, Fathi AT, DeAngelo DJ, Wadleigh M, Ballen KK, Amrein PC, Stone RM, Temel JS. Potentially avoidable hospital admissions in older patients with acute myeloid leukaemia in the USA: a retrospective analysis. Lancet Haematol. 2016 Jun; 3(6):e276-83. PMID: 27264037.
    Citations:    Fields:    Translation:Humans
  47. Abel GA, Albelda R, Khera N, Hahn T, Salas Coronado DY, Odejide OO, Bona K, Tucker-Seeley R, Soiffer R. Financial Hardship and Patient-Reported Outcomes after Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant. 2016 08; 22(8):1504-1510. PMID: 27184627.
    Citations: 9     Fields:    Translation:Humans
  48. Stuver SO, McNiff K, Fraile B, Odejide O, Abel GA, Dodek A, Jacobson JO. Novel Data Sharing Between a Comprehensive Cancer Center and a Private Payer to Better Understand Care at the End of Life. J Pain Symptom Manage. 2016 08; 52(2):161-9. PMID: 27033156.
    Citations:    Fields:    Translation:Humans
  49. Abel GA, Efficace F, Buckstein RJ, Tinsley S, Jurcic JG, Martins Y, Steensma DP, Watts CD, Raza A, Lee SJ, List AF, Klaassen RJ. Prospective international validation of the Quality of Life in Myelodysplasia Scale (QUALMS). Haematologica. 2016 06; 101(6):781-8. PMID: 26944474.
    Citations: 4     Fields:    Translation:HumansPHPublic Health
  50. Fletcher SA, Cronin AM, Zeidan AM, Odejide OO, Gore SD, Davidoff AJ, Steensma DP, Abel GA. Intensity of end-of-life care for patients with myelodysplastic syndromes: Findings from a large national database. Cancer. 2016 Apr 15; 122(8):1209-15. PMID: 26914833.
    Citations: 5     Fields:    Translation:Humans
  51. Abel GA, Cronin AM, Odejide OO, Uno H, Stone RM, Steensma DP. Influence of patient and provider characteristics on quality of care for the myelodysplastic syndromes. Br J Haematol. 2016 06; 173(5):713-21. PMID: 26913376.
    Citations: 1     Fields:    Translation:Humans
  52. Odejide OO, Cronin AM, Condron N, Earle CC, Wolfe J, Abel GA. Timeliness of End-of-Life Discussions for Blood Cancers: A National Survey of Hematologic Oncologists. JAMA Intern Med. 2016 Feb; 176(2):263-5. PMID: 26720644.
    Citations: 3     Fields:    Translation:Humans
  53. Abel GA, Buckstein R. Integrating Frailty, Comorbidity, and Quality of Life in the Management of Myelodysplastic Syndromes. Am Soc Clin Oncol Educ Book. 2016; 35:e337-44. PMID: 27249740.
    Citations:    Fields:    Translation:HumansCells
  54. Keenan T, Abel GA, Steensma DP, LeBlanc TW, Traeger L, Fathi AT, DeAngelo DJ, Wadleigh M, Hobbs G, Amrein PC, Stone RM, Ballen KK, Chen YA, Temel JS. Potentially avoidable hospitalizations in older patients with acute myeloid leukemia (AML). J Clin Oncol. 2015 Oct 10; 33(29_suppl):206. PMID: 28148109.
    Citations:    
  55. Cronin A, Watts CD, Steensma DP, Stone RM, DeAngelo DJ, Owens RL, Wadleigh M, Abel GA. Impact of sleep disturbance in myelodysplastic syndromes (MDS). J Clin Oncol. 2015 Oct 10; 33(29_suppl):99. PMID: 28148038.
    Citations:    
  56. Odejide OO, Cronin AM, Earle CC, LaCasce AS, Abel GA. Hospice Use Among Patients With Lymphoma: Impact of Disease Aggressiveness and Curability. J Natl Cancer Inst. 2016 Jan; 108(1). PMID: 26438575.
    Citations: 7     Fields:    Translation:Humans
  57. Abel GA, Cronin AM, Earles K, Gray SW. Accessibility and Quality of Online Cancer-Related Clinical Trial Information for Naïve Searchers. Cancer Epidemiol Biomarkers Prev. 2015 Oct; 24(10):1629-31. PMID: 26265204.
    Citations: 3     Fields:    Translation:Humans
  58. Fega KR, Abel GA, Motyckova G, Sherman AE, DeAngelo DJ, Steensma DP, Galinsky I, Wadleigh M, Stone RM, Driver JA. Non-hematologic predictors of mortality improve the prognostic value of the international prognostic scoring system for MDS in older adults. J Geriatr Oncol. 2015 Jul; 6(4):288-98. PMID: 26073533.
    Citations: 4     Fields:    Translation:Humans
  59. El-Jawahri AR, Abel GA, Steensma DP, LeBlanc TW, Fathi AT, Graubert TA, DeAngelo DJ, Wadleigh M, Ballen KK, Foster JE, Attar EC, Amrein PC, Brunner AM, Stone RM, Temel JS. Health care utilization and end-of-life care for older patients with acute myeloid leukemia. Cancer. 2015 Aug 15; 121(16):2840-8. PMID: 25926135.
    Citations: 8     Fields:    Translation:Humans
  60. Abel GA. Does surveillance imaging after treatment for diffuse large B-cell lymphoma really work? J Clin Oncol. 2015 May 01; 33(13):1427-9. PMID: 25823731.
    Citations: 2     Fields:    Translation:Humans
  61. Dabaja BS, Vanderplas AM, Crosby-Thompson AL, Abel GA, Czuczman MS, Friedberg JW, Gordon LI, Kaminski M, Niland J, Millenson M, Nademanee AP, Zelenetz A, LaCasce AS, Rodriguez MA. Radiation for diffuse large B-cell lymphoma in the rituximab era: analysis of the National Comprehensive Cancer Network lymphoma outcomes project. Cancer. 2015 Apr 01; 121(7):1032-9. PMID: 25492236.
    Citations: 4     Fields:    Translation:Humans
  62. Bona K, London WB, Guo D, Abel G, Lehmann L, Wolfe J. Prevalence and impact of financial hardship among New England pediatric stem cell transplantation families. Biol Blood Marrow Transplant. 2015 Feb; 21(2):312-8. PMID: 25445021.
    Citations: 4     Fields:    Translation:Humans
  63. Klaassen R, Efficace F, Buckstein R, Tinsley S, Watts CD, Jurcic JG, Abel GA. Measuring quality of life in chronic hematologic malignancy: The QUALMS-1. J Clin Oncol. 2014 Oct 20; 32(30_suppl):263. PMID: 28141305.
    Citations:    
  64. Salas Coronado D, Watts CD, Wright AA, Abel GA. Quality of end-of-life care: Are blood cancers different? J Clin Oncol. 2014 Oct 20; 32(30_suppl):195. PMID: 28141458.
    Citations:    
  65. Fraile B, Donohue CC, Odejide OO, Abel GA, Dodek A, Fallon JA, Jacobson JO. Novel data sharing between a comprehensive cancer center and a private payer to better understand care at the end of life. J Clin Oncol. 2014 Oct 20; 32(30_suppl):1. PMID: 28141274.
    Citations:    
  66. Odejide OO, Salas Coronado DY, Watts CD, Wright AA, Abel GA. End-of-life care for blood cancers: a series of focus groups with hematologic oncologists. J Oncol Pract. 2014 Nov; 10(6):e396-403. PMID: 25294393.
    Citations: 14     Fields:    Translation:Humans
  67. Uno H, Cronin AM, Wadleigh M, Schrag D, Abel GA. Derivation and validation of the SEER-Medicare myelodysplastic syndromes risk score (SMMRS). Leuk Res. 2014 Dec; 38(12):1420-4. PMID: 25443886.
    Citations: 2     Fields:    Translation:Humans
  68. Odejide OO, Cronin AM, Davidoff AJ, LaCasce AS, Abel GA. Limited stage diffuse large B-cell lymphoma: comparative effectiveness of treatment strategies in a large cohort of elderly patients. Leuk Lymphoma. 2015 Mar; 56(3):716-24. PMID: 24913508.
    Citations: 6     Fields:    Translation:Humans
  69. Tucker-Seeley RD, Abel GA, Uno H, Prigerson H. Financial hardship and the intensity of medical care received near death. Psychooncology. 2015 May; 24(5):572-8. PMID: 25052138.
    Citations: 7     Fields:    Translation:Humans
  70. Abel GA. Public advertising by cancer centers: are more data needed? Ann Intern Med. 2014 Jun 17; 160(12):870-1. PMID: 24862947.
    Citations: 1     Fields:    Translation:Humans
  71. Herrera AF, Crosby-Thompson A, Friedberg JW, Abel GA, Czuczman MS, Gordon LI, Kaminski MS, Millenson MM, Nademanee AP, Niland JC, Rodig SJ, Rodriguez MA, Zelenetz AD, LaCasce AS. Comparison of referring and final pathology for patients with T-cell lymphoma in the National Comprehensive Cancer Network. Cancer. 2014 Jul 01; 120(13):1993-9. PMID: 24706502.
    Citations: 3     Fields:    Translation:Humans
  72. Odejide OO, Jacobson JO, Abel GA. Reply to quality control of bone marrow aspirates: additional steps toward a safer and more efficient procedure. Cancer. 2014 May 01; 120(9):1442. PMID: 24481832.
    Citations:    Fields:    Translation:HumansCells
  73. Abel GA, Klaassen R, Lee SJ, Young NL, Cannella L, Steensma DP, Efficace F. Patient-reported outcomes for the myelodysplastic syndromes: a new MDS-specific measure of quality of life. Blood. 2014 Jan 16; 123(3):451-2. PMID: 24434998.
    Citations: 8     Fields:    Translation:Humans
  74. Dusetzina SB, Winn AN, Abel GA, Huskamp HA, Keating NL. Cost sharing and adherence to tyrosine kinase inhibitors for patients with chronic myeloid leukemia. J Clin Oncol. 2014 Feb 01; 32(4):306-11. PMID: 24366936.
    Citations: 54     Fields:    Translation:Humans
  75. Waldman LT, Svoboda L, Young BF, Abel GA, Berlin S, Elfiky AA, Freedman RA, Drews M, Holland L, Lathan CS. A novel community-based delivery model to combat cancer disparities. Healthc (Amst). 2013 Dec; 1(3-4):123-9. PMID: 26249781.
    Citations: 1     Fields:    
  76. Waldman LT, Bean W, Levine AL, Cohen-Bearak A, Phelps FA, Svoboda L, Freedman R, Elfiky A, Berlin S, Abel GA, Deutsch C, Lathan CS. Using FastTrack to Implement an Academic Medical Center and Community Health Center Collaborative for Cancer Care Delivery. Healthc (Amst). 2013 Dec; 1(3-4):130-135. PMID: 24516792.
    Citations:    Fields:    
  77. Zhou Z, Sehn LH, Rademaker AW, Gordon LI, Lacasce AS, Crosby-Thompson A, Vanderplas A, Zelenetz AD, Abel GA, Rodriguez MA, Nademanee A, Kaminski MS, Czuczman MS, Millenson M, Niland J, Gascoyne RD, Connors JM, Friedberg JW, Winter JN. An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era. Blood. 2014 Feb 06; 123(6):837-42. PMID: 24264230.
    Citations: 87     Fields:    Translation:Humans
  78. Ban-Hoefen M, Vanderplas A, Crosby-Thompson AL, Abel GA, Czuczman MS, Gordon LI, Kaminski MS, Kelly J, Millenson M, Nademanee AP, Rodriguez MA, Zelenetz AD, Niland J, LaCasce AS, Friedberg JW. Transformed non-Hodgkin lymphoma in the rituximab era: analysis of the NCCN outcomes database. Br J Haematol. 2013 Nov; 163(4):487-95. PMID: 24111533.
    Citations: 4     Fields:    Translation:Humans
  79. Efficace F, Baccarani M, Breccia M, Saussele S, Abel G, Caocci G, Guilhot F, Cocks K, Naeem A, Sprangers M, Oerlemans S, Chie W, Castagnetti F, Bombaci F, Sharf G, Cardoni A, Noens L, Pallua S, Salvucci M, Nicolatou-Galitis O, Rosti G, Mandelli F. International development of an EORTC questionnaire for assessing health-related quality of life in chronic myeloid leukemia patients: the EORTC QLQ-CML24. Qual Life Res. 2014 Apr; 23(3):825-36. PMID: 24026634.
    Citations: 14     Fields:    Translation:Humans
  80. Odejide OO, Cronin AM, DeAngelo DJ, Bernazzoli ZA, Jacobson JO, Rodig SJ, LaCasce AS, Mazeika TJ, Earles KD, Abel GA. Improving the quality of bone marrow assessment: Impact of operator techniques and use of a specimen preparation checklist. Cancer. 2013 Oct 01; 119(19):3472-8. PMID: 23921812.
    Citations: 2     Fields:    Translation:HumansCells
  81. Evens AM, Vanderplas A, LaCasce AS, Crosby AL, Nademanee AP, Kaminski MS, Abel GA, Millenson M, Czuczman MS, Rodriguez MA, Niland J, Zelenetz AD, Gordon LI, Friedberg JW. Stem cell transplantation for follicular lymphoma relapsed/refractory after prior rituximab: a comprehensive analysis from the NCCN lymphoma outcomes project. Cancer. 2013 Oct 15; 119(20):3662-71. PMID: 23921646.
    Citations: 10     Fields:    Translation:Humans
  82. Sherman AE, Motyckova G, Fega KR, Deangelo DJ, Abel GA, Steensma D, Wadleigh M, Stone RM, Driver JA. Geriatric assessment in older patients with acute myeloid leukemia: a retrospective study of associated treatment and outcomes. Leuk Res. 2013 Sep; 37(9):998-1003. PMID: 23747082.
    Citations: 18     Fields:    Translation:Humans
  83. Warren JL, Harlan LC, Stevens J, Little RF, Abel GA. Multiple myeloma treatment transformed: a population-based study of changes in initial management approaches in the United States. J Clin Oncol. 2013 Jun 01; 31(16):1984-9. PMID: 23569317.
    Citations: 20     Fields:    Translation:Humans
  84. Abel GA, Koreth J. Optimal positioning of hematopoietic stem cell transplantation for older patients with myelodysplastic syndromes. Curr Opin Hematol. 2013 Mar; 20(2):150-6. PMID: 23298879.
    Citations: 7     Fields:    Translation:Humans
  85. Abou-Nassar KE, Vanderplas A, Friedberg JW, Abel GA, Niland J, Rodriguez MA, Czuczman MS, Millenson M, Crosby A, Gordon LI, Zelenetz AD, Kaminski M, Lacasce AS. Patterns of use of 18-fluoro-2-deoxy-D-glucose positron emission tomography for initial staging of grade 1-2 follicular lymphoma and its impact on initial treatment strategy in the National Comprehensive Cancer Network Non-Hodgkin Lymphoma Outcomes database. Leuk Lymphoma. 2013 Oct; 54(10):2155-62. PMID: 23343180.
    Citations: 1     Fields:    Translation:Humans
  86. Abel GA, Chen K, Taback N, Hassett MJ, Schrag D, Weeks JC. Impact of oncology-related direct-to-consumer advertising: association with appropriate and inappropriate prescriptions. Cancer. 2013 Mar 01; 119(5):1065-72. PMID: 23132702.
    Citations: 5     Fields:    Translation:Humans
  87. Okam MM, Mandell E, Hevelone N, Wentz R, Ross A, Abel GA. Comparative rates of adverse events with different formulations of intravenous iron. Am J Hematol. 2012 Nov; 87(11):E123-4. PMID: 22965928.
    Citations: 5     Fields:    Translation:Humans
  88. Abel GA, Friese CR, Neville BA, Wilson KM, Hastings BT, Earle CC, Keating NL, Richardson LC. Referrals for suspected hematologic malignancy: a survey of primary care physicians. Am J Hematol. 2012 Jun; 87(6):634-6. PMID: 22473854.
    Citations: 2     Fields:    Translation:Humans
  89. Gray SW, Abel GA. Update on Direct-to-Consumer Marketing in Oncology. J Oncol Pract. 2012 Mar; 8(2):124-7. PMID: 23077440.
    Citations: 6     Fields:    
  90. Abel GA, Vanderplas A, Rodriguez MA, Crosby AL, Czuczman MS, Niland JC, Gordon LI, Millenson M, Zelenetz AD, Friedberg JW, LaCasce AS. High rates of surveillance imaging for treated diffuse large B-cell lymphoma: findings from a large national database. Leuk Lymphoma. 2012 Jun; 53(6):1113-6. PMID: 22098406.
    Citations: 7     Fields:    Translation:HumansPHPublic Health
  91. LaCasce AS, Vandergrift JL, Rodriguez MA, Abel GA, Crosby AL, Czuczman MS, Nademanee AP, Blayney DW, Gordon LI, Millenson M, Vanderplas A, Lepisto EM, Zelenetz AD, Niland J, Friedberg JW. Comparative outcome of initial therapy for younger patients with mantle cell lymphoma: an analysis from the NCCN NHL Database. Blood. 2012 Mar 01; 119(9):2093-9. PMID: 22234679.
    Citations: 15     Fields:    Translation:Humans
  92. Kumar A, Vanderplas A, LaCasce AS, Rodriguez MA, Crosby AL, Lepisto E, Czuczman MS, Nademanee A, Niland J, Gordon LI, Millenson M, Zelenetz AD, Friedberg JW, Abel GA. Lack of benefit of central nervous system prophylaxis for diffuse large B-cell lymphoma in the rituximab era: findings from a large national database. Cancer. 2012 Jun 01; 118(11):2944-51. PMID: 22006274.
    Citations: 14     Fields:    Translation:Humans
  93. Bertrand KA, Chang ET, Abel GA, Zhang SM, Spiegelman D, Qureshi AA, Laden F. Sunlight exposure, vitamin D, and risk of non-Hodgkin lymphoma in the Nurses' Health Study. Cancer Causes Control. 2011 Dec; 22(12):1731-41. PMID: 21987081.
    Citations: 11     Fields:    Translation:Humans
  94. Abel GA. The real world: CLL. Blood. 2011 Mar 31; 117(13):3481-2. PMID: 21454464.
    Citations: 1     Fields:    
  95. Yung RL, Chen K, Abel GA, Gesten FC, Roohan PJ, Boscoe FP, Sinclair AH, Schymura MJ, Schrag D. Cancer disparities in the context of Medicaid insurance: a comparison of survival for acute myeloid leukemia and Hodgkin's lymphoma by Medicaid enrollment. Oncologist. 2011; 16(8):1082-91. PMID: 21873583.
    Citations: 4     Fields:    Translation:Humans
  96. Friese CR, Earle CC, Magazu LS, Brown JR, Neville BA, Hevelone ND, Richardson LC, Abel GA. Timeliness and quality of diagnostic care for medicare recipients with chronic lymphocytic leukemia. Cancer. 2011 Apr 01; 117(7):1470-7. PMID: 21425148.
    Citations: 8     Fields:    Translation:Humans
  97. Abel GA, Bertrand KA, Earle CC, Laden F. Outcomes for lymphoid malignancies in the Nurses' Health Study (NHS) as compared to the Surveillance, Epidemiology and End Results (SEER) Program. Hematol Oncol. 2010 Sep; 28(3):133-6. PMID: 19866451.
    Citations: 3     Fields:    Translation:Humans
  98. Abel GA, Van Bennekom CM, Stone RM, Anderson TE, Kaufman DW. Classification of the myelodysplastic syndrome in a national registry of recently diagnosed patients. Leuk Res. 2010 Jul; 34(7):939-41. PMID: 20138359.
    Citations: 1     Fields:    Translation:Humans
  99. Abel GA, Burstein HJ, Hevelone ND, Weeks JC. Cancer-related direct-to-consumer advertising: awareness, perceptions, and reported impact among patients undergoing active cancer treatment. J Clin Oncol. 2009 Sep 01; 27(25):4182-7. PMID: 19652071.
    Citations: 14     Fields:    Translation:Humans
  100. Friese CR, Abel GA, Magazu LS, Neville BA, Richardson LC, Earle CC. Diagnostic delay and complications for older adults with multiple myeloma. Leuk Lymphoma. 2009 Mar; 50(3):392-400. PMID: 19294556.
    Citations: 13     Fields:    Translation:Humans
  101. LaCasce AS, Kho ME, Friedberg JW, Niland JC, Abel GA, Rodriguez MA, Czuczman MS, Millenson MM, Zelenetz AD, Weeks JC. Comparison of referring and final pathology for patients with non-Hodgkin's lymphoma in the National Comprehensive Cancer Network. J Clin Oncol. 2008 Nov 01; 26(31):5107-12. PMID: 18768434.
    Citations: 19     Fields:    Translation:Humans
  102. Abel GA, Neufeld EJ, Sorel M, Weeks JC. Direct-to-consumer advertising for bleeding disorders: a content analysis and expert evaluation of advertising claims. J Thromb Haemost. 2008 Oct; 6(10):1680-4. PMID: 18647231.
    Citations: 4     Fields:    Translation:Humans
  103. Abel GA, Friese CR, Magazu LS, Richardson LC, Fernandez ME, De Zengotita JJ, Earle CC. Delays in referral and diagnosis for chronic hematologic malignancies: a literature review. Leuk Lymphoma. 2008 Jul; 49(7):1352-9. PMID: 18604724.
    Citations: 7     Fields:    Translation:Humans
  104. Abel GA, DeAngelo DJ, Connors JM, Sholl LM, McCaffrey RP, Longtine JA. Clinical JAK2V617F mutation testing: Limited utility for general hospital patients with venous and arterial thromboses in common locations. Am J Hematol. 2008 Jun; 83(6):519-20. PMID: 18306358.
    Citations:    Fields:    Translation:Humans
  105. Abel GA, Glinert LH. Chemotherapy as language: sound symbolism in cancer medication names. Soc Sci Med. 2008 Apr; 66(8):1863-9. PMID: 18243458.
    Citations: 2     Fields:    Translation:Humans
  106. Abel GA, Lee SJ, Weeks JC. Direct-to-consumer advertising in oncology: a content analysis of print media. J Clin Oncol. 2007 Apr 01; 25(10):1267-71. PMID: 17401016.
    Citations: 13     Fields:    Translation:Humans
  107. Abel GA, Penson RT, Joffe S, Schapira L, Chabner BA, Lynch TJ. Direct-to-consumer advertising in oncology. Oncologist. 2006 Feb; 11(2):217-26. PMID: 16476842.
    Citations: 6     Fields:    Translation:Humans
  108. Abel GA, Hays JT, Decker PA, Croghan GA, Kuter DJ, Rigotti NA. Effects of biochemically confirmed smoking cessation on white blood cell count. Mayo Clin Proc. 2005 Aug; 80(8):1022-8. PMID: 16092581.
    Citations: 6     Fields:    Translation:HumansCellsPHPublic HealthCTClinical Trials
  109. Abel GA. Reporting enrollment in clinical trials. Ann Intern Med. 2002 Dec 17; 137(12):1007-8; author reply 1007-8. PMID: 12484722.
    Citations:    Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Abel's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (319)
Explore
_
Co-Authors (76)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.